Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system.

Wilhelm CJ, Johnson RA, Lysko PG, Eshleman AJ, Janowsky A.

J Pharmacol Exp Ther. 2004 Sep;310(3):1142-51. Epub 2004 Apr 21.

PMID:
15102929
2.

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

Yue Tl TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, Hart TK, Buckingham RE, Ohlstein EH.

Circulation. 2001 Nov 20;104(21):2588-94.

PMID:
11714655
3.

A comparison of carvedilol and metoprolol antioxidant activities in vitro.

Lysko PG, Webb CL, Gu JL, Ohlstein EH, Ruffolo RR Jr, Yue TL.

J Cardiovasc Pharmacol. 2000 Aug;36(2):277-81.

PMID:
10942172
4.

Molecular characterization of a human scavenger receptor, human MARCO.

Elshourbagy NA, Li X, Terrett J, Vanhorn S, Gross MS, Adamou JE, Anderson KM, Webb CL, Lysko PG.

Eur J Biochem. 2000 Feb;267(3):919-26.

5.

Induced expression of adipophilin mRNA in human macrophages stimulated with oxidized low-density lipoprotein and in atherosclerotic lesions.

Wang X, Reape TJ, Li X, Rayner K, Webb CL, Burnand KG, Lysko PG.

FEBS Lett. 1999 Nov 26;462(1-2):145-50.

6.
7.
8.

Identification of a small-molecule, nonpeptide macrophage scavenger receptor antagonist.

Lysko PG, Weinstock J, Webb CL, Brawner ME, Elshourbagy NA.

J Pharmacol Exp Ther. 1999 Jun;289(3):1277-85.

PMID:
10336517
9.

Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain.

Liu D, Smith CL, Barone FC, Ellison JA, Lysko PG, Li K, Simpson IA.

Brain Res Mol Brain Res. 1999 May 7;68(1-2):29-41.

PMID:
10320781
10.

BMP-2 gene expression and effects on human vascular smooth muscle cells.

Willette RN, Gu JL, Lysko PG, Anderson KM, Minehart H, Yue T.

J Vasc Res. 1999 Mar-Apr;36(2):120-5.

PMID:
10213907
11.

Neuroprotective activities of carvedilol and a hydroxylated derivative: role of membrane biophysical interactions.

Lysko PG, Lysko KA, Webb CL, Feuerstein G, Mason PE, Walter MF, Mason RP.

Biochem Pharmacol. 1998 Dec 15;56(12):1645-56.

PMID:
9973186
12.

Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat.

Wang X, Ellison JA, Siren AL, Lysko PG, Yue TL, Barone FC, Shatzman A, Feuerstein GZ.

J Neurochem. 1998 Sep;71(3):1194-204.

13.

Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines.

Gupta SK, Lysko PG, Pillarisetti K, Ohlstein E, Stadel JM.

J Biol Chem. 1998 Feb 13;273(7):4282-7.

14.

Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages.

Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M.

Exp Cell Res. 1997 Nov 25;237(1):46-54.

PMID:
9417865
15.
16.

Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury.

Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ.

Stroke. 1997 Jun;28(6):1233-44.

PMID:
9183357
17.
18.

SB 201823-A antagonizes calcium currents in central neurons and reduces the effects of focal ischemia in rats and mice.

Barone FC, Lysko PG, Price WJ, Feuerstein G, al-Baracanji KA, Benham CD, Harrison DC, Harries MH, Bailey SJ, Hunter AJ.

Stroke. 1995 Sep;26(9):1683-9; discussion 1689-90.

PMID:
7660415
19.

Developmental expression of endothelin receptors in cerebellar neurons differentiating in culture.

Lysko PG, Elshourbagy NA, Pullen M, Nambi P.

Brain Res Dev Brain Res. 1995 Aug 28;88(1):96-101.

PMID:
7493411
20.
21.

Binding of the nonpeptide antagonist, SB 209670, to endothelin receptors on cultured neurons.

Lysko PG, Webb CL, Feuerstein G.

Peptides. 1995;16(7):1279-82.

PMID:
8545251
23.

Carvedilol, a new antihypertensive drug with unique antioxidant activity: potential role in cerebroprotection.

Yue TL, Lysko PG, Barone FC, Gu JL, Ruffolo RR Jr, Feuerstein GZ.

Ann N Y Acad Sci. 1994 Nov 17;738:230-42. Review.

PMID:
7832432
24.

A comparison of (+)SK&F 10047 and MK-801 on cortical spreading depression.

Willette RN, Lysko PG, Sauermelch CF.

Brain Res. 1994 Jun 20;648(2):347-51.

PMID:
7922552
25.
26.

SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.

Yue TL, Mckenna PJ, Lysko PG, Gu JL, Lysko KA, Ruffolo RR Jr, Feuerstein GZ.

Eur J Pharmacol. 1994 Jan 14;251(2-3):237-43.

PMID:
8149979
27.

Neuroprotective effects of carvedilol, a new antihypertensive, at the N-methyl-D-aspartate receptor.

Lysko PG, Lysko KA, Webb CL, Feuerstein G.

Neurosci Lett. 1992 Dec 14;148(1-2):34-8.

PMID:
1300500
28.

Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper.

Yue TL, McKenna PJ, Lysko PG, Ruffolo RR Jr, Feuerstein GZ.

Atherosclerosis. 1992 Dec;97(2-3):209-16.

PMID:
1361324
29.

Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats.

Sirén AL, Heldman E, Doron D, Lysko PG, Yue TL, Liu Y, Feuerstein G, Hallenbeck JM.

Stroke. 1992 Nov;23(11):1643-50; discussion 1650-1.

PMID:
1440713
30.

Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia.

Lysko PG, Lysko KA, Yue TL, Webb CL, Gu JL, Feuerstein G.

Stroke. 1992 Nov;23(11):1630-5; discussion 1635-6.

PMID:
1440712
31.

Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.

Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, Lysko KA, Davis LL, Feuerstein G.

J Pharmacol Exp Ther. 1992 Oct;263(1):92-8.

PMID:
1357162
32.

Neuroprotective mechanism of (+)SKF 10,047 in vitro and in gerbil global brain ischemia.

Lysko PG, Yue TL, Gu JL, Feuerstein G.

Stroke. 1992 Sep;23(9):1319-23; discussion 1324.

PMID:
1519289
33.

Effects of coronary angioplasty on plasma platelet-activating factor in man.

Eldar M, Lysko PG, Schulhoff N, Gagnon RC, Feuerstein G, Shani J.

J Lipid Mediat. 1992 Sep;5(3):313-9.

PMID:
1467464
34.

CGRP stimulates the adhesion of leukocytes to vascular endothelial cells.

Sung CP, Arleth AJ, Aiyar N, Bhatnagar PK, Lysko PG, Feuerstein G.

Peptides. 1992 May-Jun;13(3):429-34.

PMID:
1326102
35.

Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons.

Yue TL, Gu JL, Lysko PG, Cheng HY, Barone FC, Feuerstein G.

Brain Res. 1992 Mar 6;574(1-2):193-7.

PMID:
1353399
36.

Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia.

Lysko PG, Gagnon RC, Yue TL, Gu JL, Feuerstein G.

Stroke. 1992 Mar;23(3):414-9.

PMID:
1542905
37.

Expression of two glucose transporters, GLUT1 and GLUT3, in cultured cerebellar neurons: Evidence for neuron-specific expression of GLUT3.

Maher F, Davies-Hill TM, Lysko PG, Henneberry RC, Simpson IA.

Mol Cell Neurosci. 1991 Aug;2(4):351-60.

PMID:
19912819
38.

Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock.

Rabinovici R, Esser KM, Lysko PG, Yue TL, Griswold DE, Hillegass LM, Bugelski PJ, Hallenbeck JM, Feuerstein G.

Circ Res. 1991 Jul;69(1):12-25.

PMID:
1647275
39.
40.

Identification of endothelin receptors in cultured cerebellar neurons.

Lysko PG, Feuerstein G, Pullen M, Wu HL, Nambi P.

Neuropeptides. 1991 Feb;18(2):83-6.

PMID:
1850120
41.
42.

Platelet-activating factor. A putative mediator in central nervous system injury?

Feuerstein G, Yue TL, Lysko PG.

Stroke. 1990 Nov;21(11 Suppl):III90-4. Review.

PMID:
2237991
43.

Effect of endothelins on cytosolic free calcium concentration in neuroblastoma NG108-15 and NCB-20 cells.

Yue TL, Gleason MM, Lysko PG, Feuerstein G.

Neuropeptides. 1990 Sep;17(1):7-12.

PMID:
2274119
44.

Production of platelet-activating factor from rat cerebellar granule cells in culture.

Yue TL, Lysko PG, Feuerstein G.

J Neurochem. 1990 May;54(5):1809-11.

PMID:
2324750
45.
46.
47.
48.

Energy-related neurotoxicity at the NMDA receptor: a possible role in Alzheimer's disease and related disorders.

Henneberry RC, Novelli A, Vigano MA, Reilly JA, Cox JA, Lysko PG.

Prog Clin Biol Res. 1989;317:143-56.

PMID:
2481321
49.

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced.

Novelli A, Reilly JA, Lysko PG, Henneberry RC.

Brain Res. 1988 Jun 7;451(1-2):205-12.

PMID:
2472189
50.

Uptake of imipramine in neurons cultured from rat cerebellum.

Novelli A, Lysko PG, Henneberry RC.

Brain Res. 1987 May 19;411(2):291-7.

PMID:
3607433

Supplemental Content

Loading ...
Support Center